This 2018 report from the Institute for Clinical and Economic Review compared the evidence for effectiveness and value of new extended-release medications for opioid use disorder (two buprenorphine injections, one buprenorphine implant, and naltrexone injection).
This is the website for Ohio’s Maternal Opiate Medical Supports (MOMS) collaborative which is working to improve maternal and baby health outcomes by providing obstetrical care and substance use disorder treatment treatment through a maternity care home model of care. The interactive website
Traditional 12-step, abstinence based substance use disorder treatment programs have generally rejected the use of medication assisted treatment (MAT) for opioid use disorder (OUD). The Recovery Research Institute provides a plain-language summary of research that looked at whether it was possible to incorporate MAT into the treatment services offered by a leading 12-step oriented treatment facility.
This 2019 systematic review assesses the evidence for the effectiveness of behavioral health interventions as part of a medication-assisted treatment (MAT) regimen for opioid use disorder (OUD). The report also evaluates clinical practice guideline recommendations for behavioral health treatments as a part of MAT and describes 3 service delivery models that implement low-threshold MAT programs in Missouri, Virginia and in the Veterans Health Administration.
This report from the National Judicial Opioid Task Force provides information about medication assisted treatment (MAT) for opioid use disorder (OUD) . It includes a description of MAT medications and legal considerations about MAT.
This 2 page information guide explains the medication assisted treatment (MAT) options for treating opioid use disorder. Intended for patients and their caregivers, it includes information on MAT options, how they work, how to access the medications,, and additional information for patients to consider when selecting a MAT option with their health care provider. Funding Source: Consumer and Prescriber Education Grant Program, National Association of Attorney Generals
A 2016 report from the Agency for Healthcare Research and Quality, this report describes 12 models of care for providing medication assisted treatment (MAT) for opioid use disorder in primary care settings.
This publication from Partnership for Drug-Free Kids provides information about medication assisted treatment (MAT) for parents and caregivers of teens and young adults with opioid use disorder.
In partnership with the National District Attorney’s Association, Addiction Policy Forum (APF) presents this free, on-line course about how district attorneys can contribute to solutions to the addiction crisis.
The Think Cultural Health website provides information, continuing education opportunities, and resources for health care professionals to learn about Culturally and Linguistically Appropriate Services (CLAS).